A

Amphastar Pharmaceuticals

AMPH

42.430
USD
-1.16
(-2.66%)
Market Open
Volume
2,309
EPS
0
Div Yield
0
P/E
16
Market Cap
2,491,207,624
Related Instruments
A
ACAD
-0.020
(-0.11%)
19.000 USD
A
ADMP
0
(0%)
0.000000 USD
A
ALKS
-0.440
(-1.61%)
26.860 USD
M
MNK
-0.06490
(-16.07%)
0.33900 USD
N
NBIX
11.660
(8.25%)
153.020 USD
P
PRGO
-0.125
(-0.44%)
28.140 USD
S
SAGE
-1.21000
(-11.03%)
9.76000 USD
T
TEVA
0.100
(0.57%)
17.530 USD
News

Title: Amphastar Pharmaceuticals

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has tworeportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.